CD19 CAR T Cells for B Cell Malignancies After Allogeneic Transplant

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01475058
Recruitment Status : Completed
First Posted : November 21, 2011
Last Update Posted : February 15, 2017
National Cancer Institute (NCI)
Information provided by (Responsible Party):
Cameron Turtle, Fred Hutchinson Cancer Research Center

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : April 2014
  Actual Study Completion Date : July 2014
  Certification/Extension First Submitted : January 31, 2017